<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02858479</url>
  </required_header>
  <id_info>
    <org_study_id>1308174</org_study_id>
    <secondary_id>2013-A01791-44</secondary_id>
    <nct_id>NCT02858479</nct_id>
  </id_info>
  <brief_title>Structural and Functional Brain Reorganization in Neuropathic Pain. Influences of the Loss of Sensitivity and the Atrophy Cortical on Activations Due to Stimulation Allodynic</brief_title>
  <acronym>ALLO</acronym>
  <official_title>Structural and Functional Brain Reorganization in Neuropathic Pain. Influences of the Loss of Sensitivity and the Atrophy Cortical on Activations Due to Stimulation Allodynic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Neuropathic pain is a medical condition involving allodynia (painful perceptions in response
      to stimuli that normally are not) and spontaneous pain (occurring at rest, without
      stimulation).

      This pain is secondary to nervous system injury affecting the sensory system. The lesion is
      either at the nerve endings of the spinal cord or brain. It induces a loss of sensitivity and
      reorganization of brain activity.

      Previous studies in functional neuroimaging have focused on brain areas activated during
      allodynic stimuli compared to non-painful stimuli. The abnormalities have been reported, but
      it was not possible to conclude formally.

      The objective of this study is to understand the brain dysfunction that induces allodynic
      pain considering the deafferentation of each patient and possible cortical losses.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 25, 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the deafferentation rate</measure>
    <time_frame>at baseline</time_frame>
    <description>measured with thermo-test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>gray matter rate.</measure>
    <time_frame>at baseline</time_frame>
    <description>measured with MRI scan</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain</measure>
    <time_frame>at baseline</time_frame>
    <description>with visual analogue scale (0 to 10)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Neuropathic Pain</condition>
  <arm_group>
    <arm_group_label>patients with pain allodynic peripheral</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with pain allodynic central</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>stimulation on painful area (area allodynic)</intervention_name>
    <description>these stimulations will be performed either with a brush, with a cold block or with forced air (cold air or air to ambient temp) : calibrated to induce pain bearable.
stimulations for 6 seconds</description>
    <arm_group_label>patients with pain allodynic peripheral</arm_group_label>
    <arm_group_label>patients with pain allodynic central</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>same stimulation on non-painful area</intervention_name>
    <description>these stimulations will be performed either with a brush, with a cold block or with forced air (cold air or air to ambient temp) : calibrated to induce pain bearable.
stimulations for 6 seconds</description>
    <arm_group_label>patients with pain allodynic peripheral</arm_group_label>
    <arm_group_label>patients with pain allodynic central</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>MRI scan</intervention_name>
    <description>2 sessions for 10 minutes :
11 controls stimulations for 6 s each spaced 20 s without stimulation.
11 allodynic stimulations for 6 s each spaced 20 s without stimulation.</description>
    <arm_group_label>patients with pain allodynic peripheral</arm_group_label>
    <arm_group_label>patients with pain allodynic central</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  with neuropathic pain

          -  in the case of central lesions, the lesion must be unique and small

          -  treatment not stable opioid for one week

          -  consent signed

        Exclusion Criteria:

          -  severe psychiatric history

          -  presence of an evolutive lesion, expansive, cancerous or tumorous underlying

          -  patient needing of opioid therapy

          -  contraindication at MRI scan
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roland PEYRON, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de SAINT-ETIENNE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Roland PEYRON, MD</last_name>
    <phone>(0)477127805</phone>
    <phone_ext>+33</phone_ext>
    <email>roland.peyron@chu-st-etienne.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carine LABRUYERE, CRA</last_name>
    <phone>(0)477120469</phone>
    <phone_ext>+33</phone_ext>
    <email>carine.labruyere@chu-st-etienne.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de SAINT-ETIENNE</name>
      <address>
        <city>Saint-etienne</city>
        <zip>42000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roland PEYRON, MD</last_name>
      <phone>(0)477127805</phone>
      <phone_ext>+33</phone_ext>
      <email>roland.peyron@chu-st-etienne.fr</email>
    </contact>
    <contact_backup>
      <last_name>Carine LABRUYERE, CRA</last_name>
      <phone>(0)477120469</phone>
      <phone_ext>+33</phone_ext>
      <email>carine.labruyere@chu-st-etienne.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 1, 2016</study_first_submitted>
  <study_first_submitted_qc>August 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2016</study_first_posted>
  <last_update_submitted>February 14, 2018</last_update_submitted>
  <last_update_submitted_qc>February 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrophy</mesh_term>
    <mesh_term>Neuralgia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

